Cyrtocymura scorpioides
Cyrtocymura scorpioides · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cyrtocymura scorpioides is a specialized botanical species often investigated for its unique pharmacological properties. In various traditional medicinal contexts, this plant is recognized for its potential role in treating snakebites. Researchers focus on its bioactive compounds to understand how it might mitigate venomous effects. To access these potent elements, scientists typically utilize an ethanolic extract for laboratory analysis. This specific preparation allows for the concentration of secondary metabolites necessary for therapeutic studies.
- Synonyms
- Cacalia Scorpioides Var. Glabriuscula · Cacalia Scorpioides · 13 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Cyrtocymura scorpioides is a plant known by a diverse array of regional common names. In certain areas, it is frequently referred to as Capichingui-de-bicho or Enxuga. It also carries the popular designation of Erva-de-preá, a name that reflects its local identity. Furthermore, many people identify this species as Erva-preá when discussing its characteristics. Finally, it is sometimes called Erva-de-são-Simão, showcasing the rich linguistic variety surrounding this single plant.
Sources: Catalogue of Life (COL)
Synonyms
Cyrtocymura scorpioides is a botanical taxon characterized by a complex web of synonymous names. Within its taxonomic history, it is frequently identified as Cacalia scorpioides. The plant also encompasses several specific varieties, including var. glabriuscula, var. subtomentosa, and var. tomentosa. Furthermore, the name Cacalia tournefortioides serves as another recognized synonym for this species. Understanding these various designations is essential for accurate identification and scientific consistency.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cyrtocymura scorpioides is a distinct botanical species belonging to the vast kingdom Plantae. Within this diverse kingdom, it is classified under the class Equisetopsida. The plant is further organized into the order Asterales, showcasing its evolutionary connections. It specifically resides within the family Asteraceae, a group known for its complex floral structures. Ultimately, this organism is identified by its unique genus, Cyrtocymura.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Cyrtocymura |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cyrtocymura scorpioides exhibits a widespread geographic range that spans across several major regions of the Americas. In the north, the species is found throughout North America and various parts of Mexico, including the southeastern territories. Its presence extends significantly into South America, where it is deeply established within the country of Brazil. Within Brazil, the plant can be located in diverse environments ranging from the northern and northeastern regions to the southern and southeastern areas. This extensive distribution highlights the remarkable adaptability of the species across different continental climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cyrtocymura scorpioides is characterized by a distinct shrub-like growth form. This plant maintains a self-supporting structure, allowing it to stand firmly within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Cyrtocymura scorpioides demonstrates significant therapeutic potential by treating both acute and chronic inflammatory processes. In experimental studies, the plant extract effectively treats 12-O-tetradecanoylphorbol acetate (TPA)-induced mouse ear oedema through dose-related inhibition. Furthermore, the extract works to treat myeloperoxidase (MPO) by reducing its activity in inflamed tissues. This includes the successful treatment of the TPA-induced increase in myeloperoxidase activity (MPO) within the ear. Ultimately, these findings confirm that the plant serves as an effective agent in treating acute cutaneous inflammation models.
Preparations
Cyrtocymura scorpioides is prepared as an ethanolic extract to investigate its potential pharmacological properties. This specific extraction method is utilized to evaluate the plant's effectiveness against both acute and chronic cutaneous inflammation models. Researchers applied the resulting ethanolic extract topically to observe its impact on ear oedema and myeloperoxidase activity. The preparation allows for the study of dose-related inhibition in inflammatory processes such as those induced by TPA and arachidonic acid. Ultimately, this ethanolic form serves as the primary agent for demonstrating the plant's anti-inflammatory capabilities.